Assistant Professor, Department of Genetics
Program for Jewish Genetic Health
The overarching mission of the Program for Jewish Genetic Health (PJGH) of Yeshiva University and Einstein is to provide a centralized resource for the Jewish community and its future generations, addressing Jewish genetic health concerns from before birth to old age. This is accomplished through education/awareness, genetic testing, and population research. Many of the directors of the PJGH are faculty at Einstein and at Montefiore Medical Center.
Please see http://einstein.yu.edu/centers/jewish-genetic-health/ for additional information and resources, including our online education program called GeneSights (www.GeneSights.com).
Schneider, A., Schreiber-Agus, N., Gross, S., et al. (2009). Population based Tay-Sachs Screening among Ashkenazi Jewish Young Adults in the 21st Century: Hexosaminidase A Enzyme Assay is Essential for Accurate Testing Am J Med Genet. Part A.149A:2444-2447.
Gross, SJ, Bajaj, K, Garry, D, Klugman, S, Karpel, BM, Roe, AM, Wagner, B, Zhan, J, Apfelroth, S, and Schreiber-Agus N. (2011). Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes. Pren Diag. 31(3):259-66.
Nakagawa, S., Zhan, J., Sun, W., Ferreira, J.C., Keiles, S., Hambuch, T., Kammesheidt, A., Mark, B., Schneider, A., Gross, S., Schreiber-Agus, N. (2012). Platelet Hexosaminidase A enzyme assay effectively detects carriers missed by targeted DNA mutation analysis. JIMD Reports. 6:1-6.
Barrett, M.J., Hagenah, J., Dhawan, V., Peng, S., Stanley, K., Raymond, D., Gross, S.J., Schreiber-Agus, N., Mirelman, A., Marder, K., Ozelius, L.J., Eidelberg, D.,Bressman, S.B., Saunders-Pullman, R., and the LRRK2 Ashkenazi Jewish Consortium. (2012). Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease. Parkinsonism Relat Disord. pii: S1353-8020(12)00348-3.
Gan-Or, Z., Ozelius, L.J., Bar-Shira, A., Saunders-Pullman, R., Mirelman, A., Kornreich, R., Gana-Weisz, M., Raymond, D., Rozenkrantz, L., Deik, A., Gurevich, T., Gross, S.J., Schreiber-Agus, N.,Giladi, N., Bressman, S.B. and Orr-Urtreger A. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology. In Press.
Schreiber-Agus, N. (2013). "The science of genetic testing.” Invited chapter for Genetics and Genetic Diseases: Jewish Legal and Ethical Perspectives, Ed. Deena Cohen Zimmerman, Ktav Publishing House.
More Information About Dr. Nicole Schreiber-Agus
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Block, Room 623
Bronx, NY 10461